Year Book of Medicine 2018

Gurpreet S Wander

TESTIMONIALS

Ozlem YALCINKAYA Library Director, Bezmialem Vakif University, Turkey

Many thanks to JAYPEEDIGITAL platform, which has been an indispensable easy-to-use source for our...

Dr Jesus Tapia Jurado Chief- Surgery Depatment, Faulty of medicine, Unversidad Nacional Autonoma de Mexico(UNAM) Mexico DF, Mexico

Jaypeedigital site offers to our students a huge number of medical publications such as textbooks...

Wan Suhaimi Ariffin, MLS (Syracuse), BLS (UITM)` Head, The National University of Malaysia (UKM), Medical Centre Library, Kuala Lumpur, Malaysia

With user-friendly interface, Jaypeedigital provides extensive coverage in medicine, dentistry and...

David E. García Díaz (MD) Head, Physiology Department, Faculty of Medicine, Universidad Nacional Autónoma de México DF, Mexico

Jaypeedigital platform presents an interesting and valuable collection of medical publications that...

Arcelia Meléndez Ocamp (MD) Head, Preventive Dentistry & Public Health Department, Universidad Nacional Autónoma de México DF, México

Some of us teach in the Division of Graduate Studies and Research at the Faculty and the contents of...

Dra. Blanca Alicia Chong Martínez Jefe de Educación Médica Continua Head of Basic Science and Continuous Medical Education Facultad Mexican de Medicina (ULSA)

It is a very complete and up-to-date platform that could be applied to all levels of the Medicine...

NEWSLETTERS

Subscribe to be the first to know about Best Deals and Exclusive Offers!

Refer to Friend

Recommend To Librarian

Share This Page

Year Book of Medicine 2018

by Gurpreet S Wander

This year book 2018 focuses on medicine. Rapid new advances and awareness of existing phenomenon are happening in the present day era of evidence based medicine. The Year Book of Medicine 2018 is an effort by experts from across the country to look at the new evidence that has been published in the medical literature in the year 2017. The book is divided into following section as Cardiology, Chest and Critical Care, Diabetes and Metabolic Disorders, Gastroenterology/Hepatology, Infectious Diseases, HIV, and TB, Miscellaneous (Geriatrics, Genetics, and Pregnancy Related), Nephrology and Hypertension, Neurology, and Rheumatology and Immunology. In each section around 20 articles have been chosen from three kinds of journals following as high impact factor journals, speciality journals, and journals with publications from India. The aim was to provide simplified commentary on the articles for the benefit of postgraduate students and practicing physicians.

Book Series: Year Book

[ Please select above dropdown to change Section ]

Chapters of the selected section will be displayed in the chapter section below.

ADD TO FAVOURITES

Book Detail

Editor	Editor's Affiliation
1. Wander Gurpreet S	Hero DMC Heart Institute, Dayanand Medical College and Hospital, Ludhiana, Punjab, India
ISBN	9789352705115
Speciality	Medicine
DOI	10.5005/jp/books/18440
Edition	1/e
Publishing Year	2018
Pages	319
Book Type	Professional

Chapters

Related Books

Antibiotic Essentials

Burke A. Cunha, Cheston B. Cunha
Role Play in MRCP-PACES

Mohammad Ali
Monograph Dengue

Sekhar Chakraborty, Nandini Chatterjee, Jyotirmoy Pal
Dr Sunil’s One Page Solutions for General Practice

K Sunil Ravinder Paul
Manual of Essential Hypertension

Nihar Mehta
Clinical Update: Lifestyle Medicine

S Arulrhaj, Vivek Chandra
Monograph on Tropical Fever

Nandini Chatterjee, Jyotirmoy Pal, Kamlesh Tewary
API Textbook of Medicine

Yash Pal Munjal, Milind Y Nadkar, Siddharth N Shah, Sandhya A Kamath
Bronchoscopy Cases

Raj Kumar
Essentials of Tuberculosis in Children

Vimlesh Seth, SK Kabra, Rakesh Lodha

	Chapter Name	Pages	Action
	Prelims	i-xxii
	Index	287-297
	Chapter-01 Nations within a Nation: Variations in Epidemiological Transition across the States of India, 1990–2016 in the Global Burden of Disease Study	1-4
	Chapter-02 Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease	5-5
	Chapter-03 System of Care for Patients with ST-segment Elevation Myocardial Infarction in India: The Tamil Nadu–ST-segment Elevation Myocardial Infarction Program	6-7
	Chapter-04 Predictors of Death in Contemporary Adult Patients with Eisenmenger Syndrome: A Multicenter Study	8-8
	Chapter-05 Midterm Results of Tetralogy of Fallot with Absent Pulmonary Valve	9-9
	Chapter-06 Meta-analysis of the Impact of Intervention versus Symptom-driven Management in Asymptomatic Severe Aortic Stenosis	10-11
	Chapter-07 Prevalence and Clinical Manifestations of Primary Aldosteronism Encountered in Primary Care Practice	12-12
	Chapter-08 Heart Failure with Preserved, Borderline, and Reduced Ejection Fraction—5-year Outcomes	13-13
	Chapter-09 Angiotensin-converting Enzyme Inhibitors and Angiotensin Receptor Blockers in High Vascular Risk	14-15
	Chapter-10 Trends in Use of High-intensity Statin Therapy after Myocardial Infarction, 2011 to 2014	16-17
	Chapter-11 Trend in Prevalence of Coronary Artery Disease and Risk Factors Over Two Decades in Rural Punjab	18-18
	Chapter-12 Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation	19-19
	Chapter-13 Implant and Midterm Outcomes of the Subcutaneous Implantable Cardioverter-Defibrillator Registry: The EFFORTLESS Study	20-21
	Chapter-14 Maternal and Fetal Outcomes of Anticoagulation in Pregnant Women with Mechanical Heart Valves	22-22
	Chapter-15 Diuretic Treatment in Heart Failure	23-24
	Chapter-16 Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease	25-25
	Chapter-17 Oxygen Therapy in Suspected Myocardial Infarction	26-26
	Chapter-18 Optimal Timing of an Invasive Strategy in Patients with Non-ST Elevation Acute Coronary Syndrome: A Meta-analysis of Randomized Trials	27-27
	Chapter-19 Fruits, Vegetables, and Legume Intake and Cardiovascular Disease and Deaths in 18 Countries (PURE): A Prospective Cohort Study	28-29
	Chapter-20 Global Mortality Variations in Patients with Heart Failure: Results from the International Congestive Heart Failure (INTER-CHF) Prospective Cohort Study	30-30
	Chapter-21 3-Year Clinical Outcomes with Everolimus-eluting Bioresorbable Coronary Scaffolds—The ABSORB III Trial	31-32
	Chapter-22 The Effects of Atorvastatin on Inflammatory Responses and Mortality in Septic Shock: A Single-center, Randomized Controlled Trial	33-33
	Chapter-23 Prevalence and Etiological Profile of Chronic Obstructive Pulmonary Disease in Nonsmokers	34-35
	Chapter-24 Pulmonary Rehabilitation in Patients with Interstitial Lung Diseases in an Outpatient Setting: A Randomized Controlled Trial	36-36
	Chapter-25 Correlation of Cutaneous Sensitivity and Cytokine Response in Children with Asthma	37-37
	Chapter-26 Clinical Profile and Treatment Outcome of Drug-resistant Tuberculosis Patients of Western Maharashtra, India	38-39
	Chapter-27 Prevalence of Aspergillus Hypersensitivity and Allergic Bronchopulmonary Aspergillosis in Patients with Bronchial Asthma at a Tertiary Care Center in North India	40-40
	Chapter-28 The Effect of Diabetes Control Status on Treatment Response in Pulmonary Tuberculosis: A Prospective Study	41-42
	Chapter-29 Efficacy and Safety of Glycopyrrolate/Formoterol Metered Dose Inhaler Formulated Using Co-Suspension Delivery Technology in Patients With COPD	43-43
	Chapter-30 Use of Mycophenolate Mofetil or Azathioprine for the Management of Chronic Hypersensitivity Pneumonitis	44-45
	Chapter-31 Early Computed Tomography Modifications Following Bronchial Thermoplasty in Patients with Severe Asthma	46-46
	Chapter-32 Nintedanib in Patients with Idiopathic Pulmonary Fibrosis and Preserved Lung Volume	47-47
	Chapter-33 Severe and Difficult-to-treat Asthma in Adults	48-49
	Chapter-34 Acute Respiratory Distress Syndrome	50-50
	Chapter-35 Evaluation of a Rapid Molecular Drug-susceptibility Test for Tuberculosis	51-52
	Chapter-36 Effect of Azithromycin on Asthma Exacerbations and Quality of Life in Adults with Persistent Uncontrolled Asthma (AMAZES): A Randomised, Double-blind, Placebo-controlled Trial	53-54
	Chapter-37 Mepolizumab for Eosinophilic Chronic Obstructive Pulmonary Disease	55-55
	Chapter-38 Tiotropium in Early-stage Chronic Obstructive Pulmonary Disease	56-57
	Chapter-39 Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism	58-58
	Chapter-40 Should Recommendations about Starting Inhaled Corticosteroid Treatment for Mild Asthma Be Based on Symptom Frequency: A Post-hoc Efficacy Analysis of the START Study	59-61
	Chapter-41 2017 Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease during Pregnancy and the Postpartum	62-62
	Chapter-42 A Systematic Review of Known Interventions for the Treatment of Chronic Non-hypovolaemic Hypotonic Hyponatraemia and a Meta-analysis of the Vaptans	63-64
	Chapter-43 Bariatric Surgery versus Intensive Medical Therapy for Diabetes—5-year Outcomes	65-66
	Chapter-44 Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes	67-68
	Chapter-45 Clinical Efficacy and Safety of Achieving Very Low LDL-cholesterol Concentrations with the PCSK9 Inhibitor Evolocumab: A Prespecified Secondary Analysis of the FOURIER trial	69-69
	Chapter-46 Clinical Outcomes of Metformin Use in Populations with Chronic Kidney Disease, Congestive Heart Failure, or Chronic Liver Disease: A Systematic Review	70-71
	Chapter-47 Cardiovascular Mortality and Morbidity in Patients with Type 2 Diabetes following Initiation of Sodium-glucose Co-transporter-2 Inhibitors versus Other Glucose-lowering Drugs (CVD-REAL Nordic): A Multinational Observational Analysis	72-72
	Chapter-48 Diabetic Foot Ulcers and Their Recurrence	73-74
	Chapter-49 Primary Care-led Weight Management for Remission of Type 2 Diabetes (DiRECT): An Open-label, Cluster-randomised Trial	75-75
	Chapter-50 Effect of Oral versus Intramuscular Vitamin D Replacement in Apparently Healthy Adults with Vitamin D Deficiency	76-77
	Chapter-51 Electrolyte Disturbances in Patients with Chronic Alcohol-use Disorder	78-79
	Chapter-52 Hashimoto’s Thyroiditis: Relative Recurrence Risk Ratio and Implications for Screening of First Degree Relatives	80-80
	Chapter-53 High Prevalence of Hypovitaminosis D in Patients Presenting with Proximal Muscle Weakness: A Sub-Himalayan Study	81-82
	Chapter-54 Liraglutide and Renal Outcomes in Type 2 Diabetes	83-84
	Chapter-55 Mortality Rates are Lower in SIAD, than in Hypervolemic or Hypovolemic Hyponatremia: Results of a Prospective Observational Study	85-85
	Chapter-56 Myopathy in Patients Taking Atorvastatin: A Pilot Study	86-86
	Chapter-57 Prevalence of Diabetes and Prediabetes in 15 States of India: Results from the ICMR–INDIAB Population-based Cross-sectional Study	87-88
	Chapter-58 Serum Vitamin B12 Levels in Type 2 Diabetes Patients on Metformin Compared to those Never on Metformin: A Cross-sectional Study	89-89
	Chapter-59 Sheehan’s Syndrome—The Most Common Cause of Panhypopituitarism at Moderate Altitude: A Sub-Himalayan Study	90-91
	Chapter-60 The Association between Subclinical Thyroid Dysfunction and Dementia: The Health, Aging, and Body Composition (Health ABC) Study	92-92
	Chapter-61 The Lipid-lowering Effect of Levothyroxine in Patients with Subclinical Hypothyroidism: A Systematic Review and Meta-analysis of Randomized Controlled Trials	93-95
	Chapter-62 A Comparison of the Rate of Gastrointestinal Bleeding in Patients Taking Non-vitamin K Antagonist Oral Anticoagulants or Warfarin	96-96
	Chapter-63 Comparing Intravenous and Oral Proton Pump Inhibitor Therapy for Bleeding Peptic Ulcers Following Endoscopic Management: A Systematic Review and Meta-analysis	97-97
	Chapter-64 Complications of Proton Pump Inhibitor Therapy	98-98
	Chapter-65 Single Center Experience of a New Endoscopic Clip in Managing Nonvariceal Upper Gastrointestinal Bleeding	99-99
	Chapter-66 ACG and CAG Clinical Guideline: Management of Dyspepsia	100-101
	Chapter-67 A Randomised Trial of Endoscopic Submucosal Dissection Versus Endoscopic Mucosal Resection for Early Barrett’s Neoplasia	102-102
	Chapter-68 Peroral Endoscopic Myotomy in Treatment-naïve Achalasia Patients Versus Prior Treatment Failure Cases	103-103
	Chapter-69 Endoscopic “Step-up Approach” Using a Dedicated Biflanged Metal Stent Reduces the Need for Direct Necrosectomy in Walled-off Necrosis (with Videos)	104-105
	Chapter-70 Association between Screen-Detected Gallstone Disease and Cancer in a Cohort Study	106-106
	Chapter-71 Efficacy of Pancreatic Enzyme Replacement Therapy in Chronic Pancreatitis: Systematic Review and Meta-analysis	107-107
	Chapter-72 Endoscopic and Clinical Responses to Antitubercular Therapy Can Differentiate Intestinal Tuberculosis from Crohn's Disease	108-109
	Chapter-73 Risk of Colorectal cancer in Asian Patients with Ulcerative Colitis: A Systemic Review and Meta-analysis	110-110
	Chapter-74 Global Prevalence of Celiac Disease: Systematic Review and Meta-analysis	111-112
	Chapter-75 Targeting the Gut-liver Axis in Liver Disease	113-113
	Chapter-76 Healthy Donor Fecal Microbiota Transplantation in Steroid-ineligible Severe Alcoholic Hepatitis: A Pilot Study	114-115
	Chapter-77 Cause, Pathogenesis, and Treatment of Nonalcoholic Steatohepatitis	116-116
	Chapter-78 Long-term Outcomes of Entecavir Monotherapy for Chronic Hepatitis B after Liver Transplantation: Results Up to 8 Years	117-117
	Chapter-79 Liver Transplantation in the Most Severely Ill Cirrhotic Patients: A Multicenter Study in Acute-on-chronic Liver Failure Grade 3	118-119
	Chapter-80 Successful Treatment of Chronic Hepatitis C Infection with Directly Acting Antivirals in Renal Transplant Recipients	120-120
	Chapter-81 L-ornithine L-aspartate in Bouts of Overt Hepatic Encephalopathy	121-122
	Chapter-82 New Drugs and Perspectives for New Antituberculosis Regimens	123-124
	Chapter-83 Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA)	125-125
	Chapter-84 Point of care Diagnostics for Tuberculosis	126-127
	Chapter-85 Index-TB Guidelines: Guidelines on Extrapulmonary Tuberculosis for India	128-129
	Chapter-86 Latent Tuberculosis Infection: Updated and Consolidated Guidelines for Programmatic Management	130-131
	Chapter-87 Enhanced Prophylaxis plus Antiretroviral Therapy for Advanced HIV Infection in Africa	132-132
	Chapter-88 HIV-TB Coinfection among 57 Million Pregnant Women, Obstetric Complications, Alcohol Use, Drug Abuse, and Depression	133-133
	Chapter-89 Survival of HIV-positive Patients Starting Antiretroviral Therapy between 1996 and 2013: A Collaborative Analysis of Cohort Studies	134-135
	Chapter-90 Prevalence of Opportunistic Infections and Causes of Death among Hospitalized HIV-infected Patients in Sichuan, China	136-136
	Chapter-91 An Overview of New Delhi Metallo-beta Lactamase-1 and Extended Spectrum Beta Lactamase Producing Bacteria: Need for an Alternate	137-138
	Chapter-92 The Antibiotic Resistance Crisis, with a Focus on the United States	139-139
	Chapter-93 Cardiovascular Complications and Short-term Mortality Risk in Community-acquired Pneumonia	140-140
	Chapter-94 Tropical Fevers in Indian Intensive Care Units: A Prospective Multicenter Study	141-142
	Chapter-95 Zika Virus Infection and Associated Neurologic Disorders in Brazil	143-143
	Chapter-96 Post-Babesiosis Warm Autoimmune Hemolytic Anemia	144-144
	Chapter-97 Recognizing Sepsis as a Global Health Priority—A WHO Resolution	145-145
	Chapter-98 A CRISPR Way to Diagnose Infectious Diseases	146-146
	Chapter-99 Typhoid Fever: A Review	147-148
	Chapter-100 Associations of Fat and Muscle Tissue with Cognitive Status in Older Adults: The AGES-Reykjavik Study	149-150
	Chapter-101 Frailty Status at Admission to Hospital Predicts Multiple Adverse Outcomes	151-152
	Chapter-102 Metabolic Syndrome and Insulin Resistance are Associated with Frailty in Older Adults: A Prospective Cohort Study	153-154
	Chapter-103 Coexistence of Metallo-beta-lactamase-encoding Genes in Pseudomonas aeruginosa	155-156
	Chapter-104 Genetic Diversity Study of Various β-lactamase-producing Multidrug-resistant Escherichia coli Isolates from a Tertiary Care Hospital Using ERIC-PCR	157-157
	Chapter-105 Characterization of Antimicrobial Resistance Markers and Their Stability in Salmonella enterica Serovar Typhi	158-158
	Chapter-106 Clonal Hematopoiesis and Risk of Atherosclerotic Cardiovascular Disease	159-160
	Chapter-107 Genetic and Pharmacologic Inactivation of ANGPTL3 and Cardiovascular Disease	161-161
	Chapter-108 Asymptomatic Osteoporosis in Indian Geriatric Population	162-163
	Chapter-109 Current Scenario of Geriatric Fungal Infections: A Prevalence Study from a Tertiary Care Hospital	164-164
	Chapter-110 SOFA Score and Critically Ill Elderly Patients	165-165
	Chapter-111 Continuous Glucose Monitoring in Pregnant Women with Type 1 Diabetes (CONCEPTT): A Multicentre International Randomized Controlled Trial	166-168
	Chapter-112 Obesity and Gynaecological and Obstetric Conditions: Umbrella Review of the Literature	169-169
	Chapter-113 Statistical Considerations for Randomized Controlled Trials [RCTs]—Understanding Superiority, Equivalence and Non-inferiority Designs	170-171
	Chapter-114 Molecular Minimal Residual Disease in Acute Myeloid Leukemia	172-173
	Chapter-115 Romosozumab or Alendronate for Fracture Prevention in Women with Osteoporosis	174-175
	Chapter-116 Trial of Solanezumab for Mild Dementia Due to Alzheimer’s Disease	176-177
	Chapter-117 Why Geriatric Medicine? A Survey of UK Specialist Trainees in Geriatric Medicine	178-179
	Chapter-118 Will Maintenance of Oral Hygiene in Nursing Home Residents Prevent Pneumonia?	180-181
	Chapter-119 Diagnostic Accuracy of Novel and Traditional Rapid Tests for Influenza Infection Compared With Reverse Transcriptase Polymerase Chain Reaction: A Systematic Review and Meta-analysis	182-182
	Chapter-120 Thyroid Hormone Therapy for Older Adults with Subclinical Hypothyroidism	183-184
	Chapter-121 The Relationship between Neutrophil to Lymphocyte Ratio and Metabolic Syndrome in Patients with Type 2 Diabetes	185-191
	Chapter-122 Prophylactic Hydration to Protect Renal Function from Intravascular Iodinated Contrast Material in Patients at High Risk of Contrast-induced Nephropathy (AMACING): A Prospective, Randomised, Phase 3, Controlled, Open-label, Non-inferiority Trial	192-192
	Chapter-123 Quantifying Postdonation Risk of ESRD in Living Kidney Donors	193-194
	Chapter-124 Kidney Outcomes Three Years after Bariatric Surgery in Severely Obese Adolescents	195-195
	Chapter-125 Food Insecurity, CKD, and Subsequent ESRD in US Adults	196-197
	Chapter-126 The Genetic Landscape of Renal Complications in Type 1 Diabetes	198-198
	Chapter-127 IgG Endopeptidase in Highly Sensitized Patients Undergoing Transplantation	199-199
	Chapter-128 Novel Treatment Protocol for Ameliorating Refractory, Chronic Pain in Patients with Autosomal Dominant Polycystic Kidney Disease	200-201
	Chapter-129 Effects of Empagliflozin on the Urinary Albumin-to-creatinine Ratio in Patients with Type 2 Diabetes and Established Cardiovascular Disease: An Exploratory Analysis from the EMPA-REG OUTCOME Randomised, Placebo-controlled Trial	202-202
	Chapter-130 Canagliflozin Slows Progression of Renal Function Decline Independently of Glycemic Effects	203-204
	Chapter-131 Single-nephron Glomerular Filtration Rate in Healthy Adults	205-205
	Chapter-132 Effects of Intensive BP Control in CKD	206-206
	Chapter-133 Intensified Multifactorial Intervention in Type 2 Diabetics with Microalbuminuria Leads to Long-term Renal Benefits	207-208
	Chapter-134 Tolvaptan in Later-stage Autosomal Dominant Polycystic Kidney Disease	209-209
	Chapter-135 A Randomized Trial of Vitamin D Supplementation on Vascular Function in CKD	210-210
	Chapter-136 Effects of Vitamin D Receptor Activation and Dietary Sodium Restriction on Residual Albuminuria in CKD: The ViRTUE-CKD Trial	211-211
	Chapter-137 Effect of Oral Methylprednisolone on Clinical Outcomes in Patients with IgA Nephropathy: The TESTING Randomized Clinical Trial	212-212
	Chapter-138 Targeted-release Budesonide versus Placebo in Patients with IgA Nephropathy (NEFIGAN): A Double-blind, Randomised, Placebo-controlled Phase 2b Trial	213-215
	Chapter-139 Multitarget Therapy for Maintenance Treatment of Lupus Nephritis	216-215
	Chapter-140 Induction and Maintenance Immunosuppression Treatment of Proliferative Lupus Nephritis: A Network Meta-analysis of Randomized Trials	216-218
	Chapter-141 Rituximab for Childhood-onset Refractory Nephrotic Syndrome (RCRNS) Study Group. Long-term Outcome of Childhood-onset Complicated Nephrotic Syndrome after a Multicenter, Double-blind, Randomized, Placebo-controlled Trial of Rituximab	219-219
	Chapter-142 Antibiotic Prophylaxis for Urinary Tract Infection-related Renal Scarring: A Systematic Review	220-220
	Chapter-143 Effect of Human Leukocyte Antigen Mismatching on the Outcomes of Pediatric Kidney Transplantation: A Systematic Review and Meta-analysis	221-222
	Chapter-144 Perinatal Diagnosis, Management, and Follow-up of Cystic Renal Diseases: A Clinical Practice Recommendation with Systematic Literature Reviews	223-223
	Chapter-145 Mycophenolate Mofetil Is Inferior to Tacrolimus in Sustaining Remission in Children with Idiopathic Steroid-resistant Nephrotic Syndrome	224-225
	Chapter-146 Global, Regional, and National Burden of Neurological Disorders During 1990-2015: A Systematic Analysis for the Global Burden of Disease Study 2015	226-226
	Chapter-147 ILAE Classification of the Epilepsies: Position Paper of the ILAE Commission for Classification and Terminology	227-228
	Chapter-148 Trial of Cannabidiol for Drug-resistant Seizures in the Dravet Syndrome	229-229
	Chapter-149 Bioequivalence between Generic and Branded Lamotrigine in People with Epilepsy: The EQUIGEN Randomized Clinical Trial	230-231
	Chapter-150 Investigations in GABAA Receptor Antibody-associated Encephalitis	232-231
	Chapter-151 DPPX Antibody-associated Encephalitis: Main Syndrome and Antibody Effects	232-232
	Chapter-152 Safety and Efficacy of Erenumab for Preventive Treatment of Chronic Migraine: A Randomized, Double-Blind, Placebo-controlled Phase 2 Trial	233-234
	Chapter-153 Referral Practice, Reporting Standards, and the Impact of Dopamine Transporter Scans Done in a Tertiary Hospital	235-236
	Chapter-154 Risk Factors for Early Psychosis in PD: Insights from the Parkinson’s Progression Markers Initiative	237-238
	Chapter-155 Cluster-randomized, Crossover Trial of Head Positioning in Acute Stroke	239-239
	Chapter-156 Family-led Rehabilitation after Stroke in India (ATTEND): A Randomized Controlled Trial	240-241
	Chapter-157 Predictors of Good Outcome after Endovascular Therapy for Vertebrobasilar Occlusion Stroke	242-242
	Chapter-158 Risk Factors, Vascular Lesion Distribution, Outcome and Recurrence of Strokes Due to Intracranial Atherosclerosis: One Year Data from Hyderabad Stroke Registry	243-244
	Chapter-159 Prevalence and Risk Factors of Asymptomatic Carotid Artery Stenosis in Indian Population: An 8-year Follow-up Study	245-245
	Chapter-160 Rapid Clinical Score for the Diagnosis of Tuberculous Meningitis: A Retrospective Cohort Study	246-246
	Chapter-161 Low-dose Aspirin and Risk of Intracranial Bleeds	247-247
	Chapter-162 Trial of Pregabalin for Acute and Chronic Sciatica	248-249
	Chapter-163 Characteristics of Nerve Conduction Studies in Carpal Tunnel Syndrome	250-251
	Chapter-164 Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis	252-252
	Chapter-165 High-dose Immunosuppressive Therapy and Autologous HCT for Relapsing-remitting MS	253-257
	Chapter-166 Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease	258-258
	Chapter-167 Baricitinib versus Placebo or Adalimumab in Rheumatoid Arthritis	259-260
	Chapter-168 Efficacy and Safety of Tofacitinib Monotherapy, Tofacitinib with Methotrexate, and Adalimumab with Methotrexate in Patients with Rheumatoid Arthritis (ORAL Strategy): A Phase 3b/4, Double-blind, Head-to-head, Randomised Controlled Trial	261-261
	Chapter-169 Tofacitinib or Adalimumab versus Placebo for Psoriatic Arthritis	262-262
	Chapter-170 Tofacitinib for Psoriatic Arthritis in Patients with an Inadequate Response to TNF Inhibitors	263-263
	Chapter-171 Trial of Tocilizumab in Giant-cell Arteritis	264-265
	Chapter-172 Incident Myocardial Infarction Associated with Major Types of Arthritis in the General Population: A Systematic Review and Meta-analysis	266-266
	Chapter-173 Rheumatoid Arthritis Triple Therapy Compared with Etanercept: Difference in Infectious and Gastrointestinal Adverse Events	267-267
	Chapter-174 Rheumatoid Arthritis Patients with Continued Low Disease Activity have Similar Outcomes Over 10 Years, Regardless of Initial Therapy	268-269
	Chapter-175 Patients with Seronegative RA Have More Inflammatory Activity Compared with Patients with Seropositive RA in an Inception Cohort of DMARD-naive Patients Classified According to the 2010 ACR/EULAR Criteria	270-270
	Chapter-176 EULAR Definition of Arthralgia Suspicious for Progression to Rheumatoid Arthritis	271-271
	Chapter-177 Mycophenolate Mofetil Versus Placebo for Systemic Sclerosis-related Interstitial Lung Disease: An Analysis of Scleroderma Lung Studies I and II	272-273
	Chapter-178 Co-occurrence and Characteristics of Patients with Axial Spondyloarthritis Who Meet Criteria for Fibromyalgia: Results from a UK National Register	274-274
	Chapter-179 A Cross-sectional Study of Cardiovascular Involvement in Systemic Lupus Erythematosus in an Urban Indian Tertiary Care Centre with Emphasis on 2-D Echocardiography	275-275
	Chapter-180 Pulmonary and Ear, Nose and Throat (ENT) Involvement in ANCA-associated Vasculitis at Diagnosis-Experience from a Tertiary Care Centre in North India	276-277
	Chapter-181 Etiology and Outcomes of Lower Limb Ulcers in Non-diabetic Patients, An Experience from Government Hospital in Western India	278-278
	Chapter-182 Effect of Disease-modifying Antirheumatic Drug Therapy on Immune Response to Trivalent Influenza Vaccine in Rheumatoid Arthritis	279-279
	Chapter-183 Clinical Experience with Two Etanercept Biosimilars in Indian Patients with Spondyloarthritis	280-280
	Chapter-184 Assessment of Extent of Skin Involvement in Scleroderma using Shear Wave Elastography	281-286